Indian pharma post-COVID: On the innovation trail?
Virat Bahri | August 30, 2020

Post-COVID-19, India needs to strengthen its pharma R&D ecosystem to tap into emerging drug development opportunities and changing paradigms in the new drug development framework.....

Read More